# Ovarian Cancer and Classification Challenges

The European Society for Radiotherapy and Oncology (ESTRO) and the European Organisation for Research and Treatment of Cancer (EORTC) developed a classification system to stratify patients with oligometastatic disease across various solid tumors. However, its application to ovarian cancer presents distinct challenges due to specific disease characteristics.

# # Disease-Specific Challenges

Ovarian cancer frequently exhibits early and diffuse peritoneal spread. Unlike other cancers, these peritoneal deposits are often difficult to measure discretely, complicating the application of standard classification systems designed for oligometastatic diseases [PubMed: PMID 42636843].

# # The Role of Radiotherapy

Historically, radiotherapy has been limited in treating ovarian cancer. The inability to deliver effective doses safely to diffuse peritoneal disease, which typically presents systemically, has constrained its use. However, stereotactic radiotherapy has recently emerged as a viable strategy for localized control in carefully selected cases.

# # Advancements and Future Directions

With the development of more effective systemic therapies, adapting the ESTRO-EORTC classification could significantly enhance patient stratification and treatment planning. The study advocates for collaboration between ESTRO, EORTC, and the European Society of Gynaecological Oncology to establish ovarian-specific guidelines for classifying peritoneal disease, thereby refining patient selection and clinical trial criteria [DOI: 10.1016/S1470-2045(26)00296-2].

# # Need for Collaborative Guidelines

The authors call for a joint initiative to create harmonized clinical practices and improve patient management through tailored classification criteria that acknowledge ovarian cancer's unique metastatic patterns. Such guidelines could enable more targeted and effective therapeutic interventions.

# # Limitations and Considerations

Although promising, the integration of these classification systems into ovarian cancer care faces challenges. The disease's unique spread patterns pose inherent difficulties in measurement and classification, highlighting the necessity of specialized, multidisciplinary approaches.

To realize the potential of these advances, continuous collaboration and research are essential to adapt existing frameworks to the specific needs of ovarian cancer patients.